• Skip to Main Content
Viatris logo
  • IndicationXALATAN® (latanoprost ophthalmic solution) is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
  • Important Safety Information
  • Prescribing Information
XALATAN (latanoprost ophthalmic solution) 0.005% logo
Image of Savings Card
Saving Mobile Logo
Get your card
Have a card? Activate
*Terms & Conditions apply.
  • Home
  • ABOUT
  • SAVINGS
  • FAQs
  • RESOURCES

Useful resources

As you move forward with brand-name XALATAN, the tools and information below can help you take an active role in managing your high eye pressure.

Resource thumbnail
HEALTH INSURANCE AND PRESCRIPTION COST TIP SHEET
Use this guide to learn about health insurance and how to get the brand-name medicine your doctor prescribed.
DOWNLOAD PDF
Resource thumbnail
BRAND SAVINGS TIP SHEET
Use this tip sheet to help ensure you receive brand-name XALATAN and save on your prescription with the XALATAN Savings Card.
DOWNLOAD PDF
Resource thumbnail
XALATAN ADMINISTRATION GUIDE AND PROGRESS TRACKER
Learn how to administer XALATAN drops and keep track of your eye pressure during treatment with the XALATAN Administration Guide & Progress Tracker. (Don't stop using your eye drops unless instructed by your doctor.)
DOWNLOAD PDF
XALATAN OFFERS SAVINGS TO PATIENTS

If eligible, patients may pay as little as $0 for each 30-day fill of brand-name XALATAN—and could save up to $1,500 a year.*

Image of Savings Card
Image of Savings Card
Get your card
Have a card? Activate
*Terms & Conditions apply.

3 Tips to get Brand-Name XALATAN

    • Prescription pad icon

      At your doctor's office:

      Ask your doctor to prescribe brand-name XALATAN and to indicate "DAW" (Dispense As Written)—or the language used in your state—on all of your XALATAN prescriptions.

    • Mortar and pestle icon

      At your pharmacy's drop-off:

      Tell the pharmacist that you want brand-name XALATAN—and be sure to use the XALATAN Savings Card if eligible.

    • Pill Bottle icon

      At your pharmacy's pick-up:

      Check your bottle to be sure it's brand-name XALATAN—not the generic—and also check that you've saved on your prescription if eligible.


      Download a Tip Sheet here.

    Learn more about XALATAN

    • Taking XALATAN
    • How to Get Brand-Name XALATAN
    • Safety & Possible Side Effects
    Scroll for Important Safety Information and Indications

    IMPORTANT SAFETY INFORMATION AND INDICATION

    collapse collapsecollapse

    XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

    XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

    XALATAN contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

    If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.

    The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.

    INDICATION

    XALATAN is a prescription medication for the treatment of high eye pressure
    /intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Please see Full Prescribing Information.

    YOU ARE NOW LEAVING XALATAN.COM, A VIATRIS INC., COMPANY WEBSITE

    The website you are about to access is not owned or controlled by VIATRIS™. Links to other websites are provided as a convenience to users and the inclusion of any link does not imply the endorsement of the linked site by Viatris. Viatris accepts no responsibility for the content of any linked sites.

    CONTINUE
    Stay on this site

    s IMPORTANT SAFETY INFORMATION AND INDICATION

    XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

    XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

    XALATAN contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

    If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.

    The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.

    INDICATION

    XALATAN is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Please see Full Prescribing Information.

    Important Safety Information and Indication

    XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

    XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

    XALATAN contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

    If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.

    The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.

    INDICATION

    XALATAN is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Please see Full Prescribing Information.


    XALATAN SAVINGS CARD TERMS AND CONDITIONS

    By participating in the XALATAN Savings Offer Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

    • This Savings Offer is not valid for prescriptions that are reimbursed, in whole or in part, by Medicaid, Medicare, TRICARE, Veterans Affairs healthcare, or any other federal or state healthcare program (including any state prescription drug assistance program), or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”)
    • The value of this Savings Offer is limited to $125 per use or the amount of your co-pay, whichever is less
    • This Savings Offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other health or pharmacy benefit programs
    • You must deduct the savings received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf
    • Eligible patients may pay a minimum of $0 per monthly prescription fill. By using this Savings Offer, eligible patients may receive a savings of up to $125 per fill off their co-pay or out-of-pocket costs. This Savings Offer is available for a maximum savings of $1,500 per year ($125 per month x 12 months). This Savings Offer may limit your prescription cost to $0, subject to a $125 maximum monthly benefit. Thus, if your co-pay or out-of-pocket cost is more than $125, you will save $125 off of your co-pay or total out-of-pocket costs. [Example: If your co-pay or out-of-pocket costs are $150, you will pay $25 ($150 – $125 = $25).] If your co-pay or out-of-pocket costs are no more than $125, you pay $0. For a mail-order 3-month prescription, your total maximum savings may be $375 ($125 x 3)
    • You must be 18 years of age or older to redeem this Savings Offer
    • Patients who are enrolled in Medicare, Medicaid, or another state or federal healthcare program may use this Savings Offer if paying for the prescription covered by this Savings Offer outside of their government insurance benefit, and no claim is submitted to Medicare, Medicaid, or any federal or state healthcare program. Such patients must not apply any out-of-pocket expenses incurred using this Savings Offer toward any government insurance benefit out-of-pocket spending calculations, such as Medicare Part D true out-of-pocket (TrOOP) costs
    • You are responsible for reporting use of this Savings Offer to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using this Savings Offer, as may be required. You should not use this Savings Offer if your insurer or health plan prohibits use of manufacturer Savings Offers
    • This Savings Offer is not valid (i) for Massachusetts residents or (ii) for California residents whose prescriptions are covered, in whole or in part, by third-party insurance
    • This Savings Offer is not valid where prohibited by law
    • This Savings Offer is not valid for purchases of prescriptions discounted under the 340B drug pricing program
    • This Savings Offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
    • This Savings Offer will be accepted only at participating pharmacies
    • This Savings Offer is not health insurance
    • This Savings Offer is good only in the U.S. and Puerto Rico
    • This Savings Offer is limited to 1 per person during this offering period and is not transferable
    • No other purchase is necessary
    • A Savings Offer may not be redeemed more than once per 30 days per patient
    • Data related to your redemption of this Savings Offer may be collected, analyzed, and shared with VIATRIS™ for market research and other purposes related to assessing Viatris' programs. Data shared with Viatris will be aggregated and de-identified; it will be combined with data related to other Savings Offer redemptions and will not identify you
    • Viatris reserves the right to rescind, revoke, or amend the program without notice
    • No membership fees. This Savings Offer and Program expire on 12/31/2023
    • Visit XALATAN.com for more information about XALATAN. For help with the XALATAN Savings Offer, call 1-866-562-6147, or write: Viatris, P.O. Box 2941, Mission, KS 66201

    If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this Savings Offer. Pay for your XALATAN prescription as you normally would. Then, make a photocopy of the front of your XALATAN Savings Card as well as the original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled, and mail them both to: XALATAN Savings, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Be sure to include your name and mailing address, and a check will be mailed to you within 3 weeks.

    XALATAN is available by prescription only.

    Patients should always ask their doctors for medical advice about adverse events.

    You are encouraged to report adverse events related to Viatris products by calling 1-877-446-3679 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit http://www.fda.gov/MedWatch or call 1-800-FDA-1088

    This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

    Important Safety Information and Indication
    +-

    XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

    XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

    XALATAN contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

    If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.

    The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.

    INDICATION

    XALATAN is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Please see Full Prescribing Information.

    XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.

    XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

    Xalatan contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.

    If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.

    The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.

    INDICATION

    XALATAN is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Please see Full Prescribing Information.

    VIATRIS Logo
    • Terms of Use
    • Privacy Policy
    • California Supplemental Disclosure
    • Site Map
    • Contact Viatris
    • About Viatris

    © 2022 Viatris Inc. All rights reserved.

    XALATAN is a registered trademark of Pfizer PFE Holdings 4 LLC, a Viatris Company. VIATRIS and the Viatris logo are trademarks of Mylan Inc., a Viatris Company.

    PP-XLT-USA-0132